Literature DB >> 11180473

Improvement in sundowning in dementia with Lewy bodies after treatment with donepezil.

A Skjerve1, H A Nygaard.   

Abstract

Sundowning, manifested as a recurring increase in restlessness and agitation in the evening, is described in a 71-year-old man with clinically diagnosed dementia with Lewy bodies. An objective measure of activity using the activity electronic monitoring technique indicated a marked increase in activity level during the evening compared to earlier in the day. After treatment with donepezil, a cholinesterase inhibitor, ratings of behavioural symptoms improved. In addition, there was a marked reduction in evening activity and an increase in daytime activity. Cognition and parkinsonism also improved. Possible explanations for this finding are discussed. Copyright 2000 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11180473     DOI: 10.1002/1099-1166(200012)15:12<1147::aid-gps262>3.0.co;2-l

Source DB:  PubMed          Journal:  Int J Geriatr Psychiatry        ISSN: 0885-6230            Impact factor:   3.485


  6 in total

1.  Altered temporal patterns of anxiety in aged and amyloid precursor protein (APP) transgenic mice.

Authors:  Tracy A Bedrosian; Kamillya L Herring; Zachary M Weil; Randy J Nelson
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-27       Impact factor: 11.205

Review 2.  Benefit-risk considerations in the treatment of dementia with Lewy bodies.

Authors:  Margaret M Swanberg; Jeffrey L Cummings
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

3.  Sundown syndrome in persons with dementia: an update.

Authors:  Nina Khachiyants; David Trinkle; Sang Joon Son; Kye Y Kim
Journal:  Psychiatry Investig       Date:  2011-11-04       Impact factor: 2.505

4.  Mild cognitive impairment in Parkinson's disease: the challenge and the promise.

Authors:  Hubert H Fernandez; Gregory P Crucian; Michael S Okun; Catherine C Price; Dawn Bowers
Journal:  Neuropsychiatr Dis Treat       Date:  2005-03       Impact factor: 2.570

Review 5.  Sundowning in Dementia: Clinical Relevance, Pathophysiological Determinants, and Therapeutic Approaches.

Authors:  Marco Canevelli; Martina Valletta; Alessandro Trebbastoni; Giuseppe Sarli; Fabrizia D'Antonio; Leonardo Tariciotti; Carlo de Lena; Giuseppe Bruno
Journal:  Front Med (Lausanne)       Date:  2016-12-27

Review 6.  Potential Pathways for Circadian Dysfunction and Sundowning-Related Behavioral Aggression in Alzheimer's Disease and Related Dementias.

Authors:  William D Todd
Journal:  Front Neurosci       Date:  2020-09-03       Impact factor: 5.152

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.